These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation. Treem WR Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412 [TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of a defect in medium-chain fatty acid oxidation. Pollitt RJ; Manning NJ; Olpin SE; Young ID J Inherit Metab Dis; 1994; 17(3):279-82. PubMed ID: 7807933 [No Abstract] [Full Text] [Related]
6. Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid. Olpin SE; Manning NJ; Pollitt RJ; Clarke S J Inherit Metab Dis; 1997 Jul; 20(3):415-9. PubMed ID: 9266370 [No Abstract] [Full Text] [Related]
7. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation. Harpey JP; Charpentier C; Paturneau-Jouas M Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221 [TBL] [Abstract][Full Text] [Related]
8. The changing face of disorders of fatty acid oxidation. Vockley J Mayo Clin Proc; 1994 Mar; 69(3):249-57. PubMed ID: 8133663 [TBL] [Abstract][Full Text] [Related]
13. A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation. Seargeant LE; Balachandra K; Mallory C; Dilling LA; Greenberg CR J Inherit Metab Dis; 1999 Aug; 22(6):740-6. PubMed ID: 10472534 [TBL] [Abstract][Full Text] [Related]
14. A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net. Rossi A; Hoogeveen IJ; Lubout CMA; de Boer F; Fokkert-Wilts MJ; Rodenburg IL; van Dam E; GrĂ¼nert SC; Martinelli D; Scarpa M; ; Dekker H; Te Boekhorst ST; van Spronsen FJ; Derks TGJ J Inherit Metab Dis; 2021 Sep; 44(5):1124-1135. PubMed ID: 33844307 [TBL] [Abstract][Full Text] [Related]
15. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects. Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH J Inherit Metab Dis; 1999 May; 22(3):302-6. PubMed ID: 10384392 [No Abstract] [Full Text] [Related]
17. [Clinical protocols concerned with disorders of fatty acid beta oxidation]. Kania M Przegl Lek; 1994; 51(1):25-8. PubMed ID: 8208992 [TBL] [Abstract][Full Text] [Related]
18. Defects of mitochondrial beta-oxidation: a growing group of disorders. Vockley J; Whiteman DA Neuromuscul Disord; 2002 Mar; 12(3):235-46. PubMed ID: 11801395 [TBL] [Abstract][Full Text] [Related]
19. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy. Tein I J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056 [TBL] [Abstract][Full Text] [Related]
20. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review. Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]